ClinicalTrials.Veeva

Menu

The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study

C

Central South University

Status

Unknown

Conditions

Other Immunological States or Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT02202460
IFMISMD (Registry Identifier)
rrw2014

Details and patient eligibility

About

Patients suffer from Serious Psychosis may have variation in immunological factors,BDNF and MRI.

Full description

Patients suffer from Schizophrenia and Mood Disorders may have variation in immunological factors(TNF-α,IL-2,IL-6,IL-10,etc),BDNF and Brain MRI.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis with Schizophrenia , Bipolar Disorder or Major Depression by DSM-5

Exclusion criteria

  • Unstable physical conditions

Trial contacts and locations

1

Loading...

Central trial contact

Renrong Wu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems